Atlas Trials

Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions

Clinical trial NCT03603106 · COMPLETED

Trial details

NCT number
NCT03603106
Sponsor
Guerbet
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Healthy VolunteersBrain Lesion
Start date
2013-11-25
Primary completion
2015-04-17
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.